{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:37Z","timestamp":1793724277225,"version":"4.6.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.breast.2024.103720","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T07:36:57Z","timestamp":1711697817000},"page":"103720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Outcomes of atypical (B3) core biopsy lesions diagnosed across BreastScreen NSW, Australia"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6027-5362","authenticated-orcid":false,"given":"Richard","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Descallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jalaludin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2911-885X","authenticated-orcid":false,"given":"Patsy S.","family":"Soon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.breast.2024.103720_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s004280050297","article-title":"Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas","volume":"434","author":"Sloane","year":"1999","journal-title":"Virchows Arch"},{"issue":"9","key":"10.1016\/j.breast.2024.103720_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jcp.2003.010983","article-title":"Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment","volume":"57","author":"Ellis","year":"2004","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.breast.2024.103720_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2559.2008.03158.x","article-title":"Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening","volume":"53","author":"El-Sayed","year":"2008","journal-title":"Histopathology."},{"issue":"8","key":"10.1016\/j.breast.2024.103720_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.crad.2018.04.004","article-title":"NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)","volume":"73","author":"Pinder","year":"2018","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.breast.2024.103720_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejso.2018.12.008","article-title":"High risk (B3) breast lesions: what is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis","volume":"45","author":"Forester","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2024.103720_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1186\/s12885-018-4742-6","article-title":"Lesions of \u201cuncertain malignant potential\u201d in the breast (B3) identified with mammography screening","volume":"18","author":"Richter-Ehrenstein","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2024.103720_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.breast.2016.11.007","article-title":"Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy","volume":"31","author":"Mayer","year":"2017","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.breast.2024.103720_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000517109","article-title":"Malignancy rate and malignancy risk assessment in different lesions of uncertain malignant potential in the breast (B3 lesions): an analysis of 192 cases from a Single institution","volume":"17","author":"Mohrmann","year":"2021","journal-title":"Breast Care"},{"issue":"4","key":"10.1016\/j.breast.2024.103720_bib10","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.clbc.2023.03.006","article-title":"The upgrade risk of B3 lesions to (Pre)Invasive breast cancer after diagnosis on core needle or vacuum assisted biopsy. A Belgian national cohort study","volume":"23","author":"Willers","year":"2023","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2024.103720_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.suronc.2020.04.002","article-title":"When to do surgical resection for atypical breast lesions: results of a prospective cohort of 518 lesions","volume":"34","author":"Cohen","year":"2020","journal-title":"Surg Oncol"},{"issue":"12","key":"10.1016\/j.breast.2024.103720_bib12","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/ans.16315","article-title":"B3 lesion upgrade rates in a tertiary Australian breast centre: a 8-year experience (2012\u20132019)","volume":"90","author":"Huang","year":"2020","journal-title":"ANZ J Surg"},{"issue":"3","key":"10.1016\/j.breast.2024.103720_bib13","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.clbc.2019.12.009","article-title":"Three-year trends in diagnosis of B3 breast lesions and their upgrade rates to malignant lesions","volume":"20","author":"Griffiths","year":"2020","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.breast.2024.103720_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.suronc.2016.04.002","article-title":"Positive predictive value of breast lesions of uncertain malignant potential (B3): can we identify high risk patients? The value of a multidisciplinary team and implications in the surgical treatment","volume":"25","author":"Taffurelli","year":"2016","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2024.103720_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-018-05071-1","article-title":"Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)","volume":"174","author":"Rageth","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2024.103720_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00428-023-03566-x","article-title":"Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)","volume":"483","author":"Elfgen","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.breast.2024.103720_bib17","series-title":"European guidelines for quality assurance in breast cancer screening and diagnosis","year":"2006"},{"issue":"5","key":"10.1016\/j.breast.2024.103720_bib18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/ans.14827","article-title":"Management of papillary lesions without atypia of the breast diagnosed on needle biopsy","volume":"89","author":"Yu","year":"2019","journal-title":"ANZ J Surg"},{"issue":"6","key":"10.1016\/j.breast.2024.103720_bib19","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/tbj.13476","article-title":"B3-lesions of the breast: risk of malignancy after vacuum-assisted breast biopsy versus core needle biopsy diagnosis","volume":"25","author":"Pozzi","year":"2019","journal-title":"Breast J"},{"issue":"3","key":"10.1016\/j.breast.2024.103720_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jclinpath-2015-203018","article-title":"Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice?","volume":"69","author":"Strachan","year":"2016","journal-title":"J Clin Pathol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624000511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624000511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:46:22Z","timestamp":1715899582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977624000511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":19,"alternative-id":["S0960977624000511"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2024.103720","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of atypical (B3) core biopsy lesions diagnosed across BreastScreen NSW, Australia","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2024.103720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103720"}}